← Leaderboards
Kojo Seys Elenitoba-Johnson
Sloan-Kettering Inst Can Research
$15,478,914
Attributed
$15,478,914
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,478,914 · 9
By mechanism
R01$14,297,751 · 6
R33$856,519 · 1
R21$224,644 · 1
R42$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Charles L Sawyers$34,701,646
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSamplingPathogenesisLymphomaDiagnosisCohortEarly DiagnosisBaseRecurrenceResponseTandem Mass SpectrometryValidationDetectionCellsProteomicsDiagnosticCharacteristicsBiologicalLymphomagenesisCommunitiesResourcesBiological MarkersMass Spectrum AnalysisCategories
Grant awards (34)
TYK2 Fusions in Lymphoma$3,111,184
R01 · FY2025 · CA · contact PI
Genomic biomarkers of splenic lymphoma$452,854
R01 · FY2025 · CA · contact PI
Genomic biomarkers of splenic lymphoma$474,188
R01 · FY2024 · CA · contact PI
Epiproteomics of Sezary Syndrome$465,523
R01 · FY2024 · CA · contact PI
Genomic biomarkers of splenic lymphoma$621,501
R01 · FY2023 · CA · contact PI
Epiproteomics of Sezary Syndrome$566,572
R01 · FY2023 · CA · contact PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis$530,765
R01 · FY2023 · CA · contact PI
Epiproteomics of Sezary Syndrome$528,744
R01 · FY2022 · CA · contact PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis$511,096
R01 · FY2022 · CA · contact PI
Genomic biomarkers of splenic lymphoma$412,171
R01 · FY2022 · CA · contact PI
Genomic biomarkers of splenic lymphoma$194,502
R01 · FY2022 · CA · contact PI
Epiproteomics of Sezary Syndrome$134,626
R01 · FY2022 · CA · contact PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis$24,884
R01 · FY2022 · CA · contact PI
Epiproteomics of Sezary Syndrome$634,378
R01 · FY2021 · CA · contact PI
Genomic biomarkers of splenic lymphoma$623,925
R01 · FY2021 · CA · contact PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis$473,302
R01 · FY2021 · CA · contact PI
Epiproteomics of Sezary Syndrome$610,351
R01 · FY2020 · CA · contact PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis$505,411
R01 · FY2020 · CA · contact PI
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis$502,130
R01 · FY2019 · CA · contact PI
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma$260,080
R01 · FY2013 · CA · contact PI
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma$277,682
R01 · FY2012 · CA · contact PI
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma$370,916
R01 · FY2011 · DE · contact PI
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma$278,653
R01 · FY2011 · CA · contact PI
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma$382,388
R01 · FY2010 · DE · contact PI
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma$288,241
R01 · FY2010 · CA · contact PI
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma$386,250
R01 · FY2009 · DE · contact PI
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma$289,184
R01 · FY2009 · CA · contact PI
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma$386,250
R01 · FY2008 · DE · contact PI
Quantitative proteomic analysis of lymphoma transformation$283,132
R33 · FY2008 · CA · contact PI
Quantitative proteomic analysis of lymphoma transformation$280,329
R33 · FY2007 · CA · contact PI
Quantitative proteomic analysis of lymphoma transformation$293,058
R33 · FY2006 · CA · contact PI
Quantitative RT-PCR: Prediction Lymphoma Transformation$100,000
R42 · FY2005 · CA
EXPRESSION PROFILING OF PROGRESSED FOLLICULAR LYMPHOMAS$112,519
R21 · FY2001 · CA
EXPRESSION PROFILING OF PROGRESSED FOLLICULAR LYMPHOMAS$112,125
R21 · FY2000 · CA